TABLE 1.
Parametera | Value for: |
|
---|---|---|
IL-6 360 min after LPS | IL-6 24 h after LPS | |
PCSK9 at baseline | ||
Pearson correlation | −0.326 | −0.181 |
P level | 0.358 | 0.618 |
HDL at baseline | ||
Pearson correlation | −0.682 | −0.793 |
P level | 0.030 | 0.006 |
ApoA1 at baseline | ||
Pearson correlation | −0.783 | −0.803 |
P level | 0.007 | 0.005 |
LDL at baseline | ||
Pearson correlation | −0.494 | −0.699 |
P level | 0.147 | 0.024 |
ApoB at baseline | ||
Pearson correlation | −0.441 | −0.610 |
P level | 0.202 | 0.061 |
Lp(a) at baseline | ||
Pearson correlation | 0.002 | −0.165 |
P level | 0.995 | 0.649 |
P values were determined by two-tailed test. Abbreviations: ApoA1, apolipoprotein A-I; ApoB, apolipoprotein B; Lp(a), lipoprotein (a).
There was a significant correlation between LDL and IL-6 at 24 h after LPS infusion. HDL and ApoA1 show significant correlations with IL-6 at both 360 min and 24 h after LPS infusion. For PCSK9 as well as ApoB, there was no significant correlation with markers of inflammation. All baseline values were measured before LPS administration.